Articles of note for people dealing with pituitary disease and related conditions.
Join a drug trial. Find out how. Here’s a partial list of studies.
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
A prolactinoma case from Dr. Blevins’ clinic
Prolactinomas in men tend to be large tumors and are often invasive.
Vasopressin Deficiency (Diabetes Insipidus); an opportunity to share your insights
From the desk of Dr.Lewis S. Blevins, Jr. – co founder – With most endocrinologic conditions, physicians prescribe medication, patients
Worth noting:
Crinetics Pharmaceuticals announces more Phase 3 paltusotine results in participants with acromegaly who were not pharmacologically treated . Read more
Pfizer announces Together with Acromegaly patient support site and Together for Rare: Understanding your insurance options video.
Two resources from Recordati: Cushing’s Conversations and Cushing’s Inspirations
Chiesi relaunches a patient-facing website for Mycapssa.
Corcept Therapeutics communication materials for Phase 3 Trial of Relacolirant for Cushing’s syndrome now available. Learn more.
Content for physicians and healthcare professionals.
The latest from pharmaceutical companies and related organizations
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Live Talk on Demand
Today’s podcast is about our super athlete friend Risa August and her new book about her acromegaly experience, her life, and her 1,800 mile ride from Canada to Mexico.
Spain and Spanish-speaking countries have been our focus as we seek to develop more content in Spanish for our edition of Pituitary Word News in Español. Today’s podcasts covers part of the conference and shares my conversations with three world-renowned Spanish endocrinologists.
In today's podcast, we talk with Giacomo Chiesi, Head of Global Rare Diseases at the Chiesi Group, where he leads a team in developing and marketing treatments for rare and ultra-rare diseases.